These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18712619)

  • 1. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer.
    Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC
    Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of pranoprofen from the ethylene-vinyl acetate matrix using plasticizer.
    Cho CW; Choi JS; Shin SC
    Drug Dev Ind Pharm; 2007 Jul; 33(7):747-53. PubMed ID: 17654023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
    Shin SC; Lee HJ
    Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
    Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
    Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Controlled Transdermal Delivery of Mexazolam Using Ethylene-vinyl Acetate.
    Weon Cho C; Chul Shin S
    Iran J Pharm Res; 2012; 11(1):3-12. PubMed ID: 25317180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the loratadine gel for enhanced transdermal delivery.
    Song JH; Shin SC
    Drug Dev Ind Pharm; 2009 Aug; 35(8):897-903. PubMed ID: 19241201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peculiar effect of polyethylene glycol in comparison with triethyl citrate or diethyl phthalate on properties of ethyl cellulose microcapsules containing propranolol hydrochloride in process of emulsion-solvent evaporation.
    Afrasiabi Garekani H; Sanadgol N; Dehghan Nayyeri N; Nokhodchi A; Sadeghi F
    Drug Dev Ind Pharm; 2018 Mar; 44(3):421-431. PubMed ID: 29098888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced transdermal delivery of loratadine from the EVA matrix.
    Cho CW; Choi JS; Kim SJ; Shin SC
    Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of plasticizer on heat-humidity curing of cellulose acetate phthalate coated beads.
    Williams RO; Liu J
    Pharm Dev Technol; 2001 Nov; 6(4):607-19. PubMed ID: 11775961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Controlled Transdermal Delivery of Ambroxol from the EVA Matrix.
    Cho CW; Kim DB; Cho HW; Shin SC
    Indian J Pharm Sci; 2012 Mar; 74(2):127-32. PubMed ID: 23325993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer.
    Tallury P; Randall MK; Thaw KL; Preisser JS; Kalachandra S
    Dent Mater; 2007 Aug; 23(8):977-82. PubMed ID: 17049593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
    Cho CW; Choi JS; Yang KH; Shin SC
    Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
    Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW
    J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
    Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of TPX polymer membranes for the controlled release of triprolidine.
    Shin SC; Yoon MK
    Int J Pharm; 2002 Jan; 232(1-2):131-7. PubMed ID: 11790496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.